156 related articles for article (PubMed ID: 24374343)
1. Overexpression of RhoGDI, a novel predictor of distant metastasis, promotes cell proliferation and migration in hepatocellular carcinoma.
Wang H; Wang B; Liao Q; An H; Li W; Jin X; Cui S; Zhao L
FEBS Lett; 2014 Jan; 588(3):503-8. PubMed ID: 24374343
[TBL] [Abstract][Full Text] [Related]
2. RhoGDI deficiency induces constitutive activation of Rho GTPases and COX-2 pathways in association with breast cancer progression.
Bozza WP; Zhang Y; Hallett K; Rivera Rosado LA; Zhang B
Oncotarget; 2015 Oct; 6(32):32723-36. PubMed ID: 26416248
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of invasion and metastasis of hepatocellular carcinoma cells via targeting RhoC in vitro and in vivo.
Wang W; Wu F; Fang F; Tao Y; Yang L
Clin Cancer Res; 2008 Nov; 14(21):6804-12. PubMed ID: 18980974
[TBL] [Abstract][Full Text] [Related]
4. Rho GDP dissociation inhibitor beta promotes cell proliferation and invasion by modulating the AKT pathway in hepatocellular carcinoma.
Fang Y; Yi J; Lizhi L; Qiucheng C
DNA Cell Biol; 2014 Nov; 33(11):781-6. PubMed ID: 25180836
[TBL] [Abstract][Full Text] [Related]
5. P21-activated protein kinase is overexpressed in hepatocellular carcinoma and enhances cancer metastasis involving c-Jun NH2-terminal kinase activation and paxillin phosphorylation.
Ching YP; Leong VY; Lee MF; Xu HT; Jin DY; Ng IO
Cancer Res; 2007 Apr; 67(8):3601-8. PubMed ID: 17440071
[TBL] [Abstract][Full Text] [Related]
6. Loss of RhoGDI is a novel independent prognostic factor in hepatocellular carcinoma.
Li W; Wang H; Jin X; Zhao L
Int J Clin Exp Pathol; 2013; 6(11):2535-41. PubMed ID: 24228117
[TBL] [Abstract][Full Text] [Related]
7. RhoE is frequently down-regulated in hepatocellular carcinoma (HCC) and suppresses HCC invasion through antagonizing the Rho/Rho-kinase/myosin phosphatase target pathway.
Ma W; Wong CC; Tung EK; Wong CM; Ng IO
Hepatology; 2013 Jan; 57(1):152-61. PubMed ID: 22829315
[TBL] [Abstract][Full Text] [Related]
8. MiR-25 promotes hepatocellular carcinoma cell growth, migration and invasion by inhibiting RhoGDI1.
Wang C; Wang X; Su Z; Fei H; Liu X; Pan Q
Oncotarget; 2015 Nov; 6(34):36231-44. PubMed ID: 26460549
[TBL] [Abstract][Full Text] [Related]
9. HOXB7 promotes tumor progression via bFGF-induced activation of MAPK/ERK pathway and indicated poor prognosis in hepatocellular carcinoma.
Wang WM; Xu Y; Wang YH; Sun HX; Sun YF; He YF; Zhu QF; Hu B; Zhang X; Xia JL; Qiu SJ; Zhou J; Yang XR; Fan J
Oncotarget; 2017 Jul; 8(29):47121-47135. PubMed ID: 28454092
[TBL] [Abstract][Full Text] [Related]
10. C9orf100, a new member of the Dbl-family guanine nucleotide exchange factors, promotes cell proliferation and migration in hepatocellular carcinoma.
Wang H; Li Y; Wang Y; Han ZG; Cai B
Mol Med Rep; 2012 May; 5(5):1169-74. PubMed ID: 22327280
[TBL] [Abstract][Full Text] [Related]
11. Tiam1 is associated with hepatocellular carcinoma metastasis.
Huang J; Ye X; Guan J; Chen B; Li Q; Zheng X; Liu L; Wang S; Ding Y; Ding Y; Chen L
Int J Cancer; 2013 Jan; 132(1):90-100. PubMed ID: 22573407
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of Rho GDP-dissociation inhibitor alpha is associated with tumor progression and poor prognosis of colorectal cancer.
Zhao L; Wang H; Li J; Liu Y; Ding Y
J Proteome Res; 2008 Sep; 7(9):3994-4003. PubMed ID: 18651761
[TBL] [Abstract][Full Text] [Related]
13. Somatic LMCD1 mutations promoted cell migration and tumor metastasis in hepatocellular carcinoma.
Chang CY; Lin SC; Su WH; Ho CM; Jou YS
Oncogene; 2012 May; 31(21):2640-52. PubMed ID: 21996735
[TBL] [Abstract][Full Text] [Related]
14. Significance of the Rac signaling pathway in HCC cell motility: implications for a new therapeutic target.
Lee TK; Man K; Ho JW; Wang XH; Poon RT; Sun CK; Ng KT; Ng IO; Xu R; Fan ST
Carcinogenesis; 2005 Mar; 26(3):681-7. PubMed ID: 15604094
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA AFAP1-AS1 indicates a poor prognosis of hepatocellular carcinoma and promotes cell proliferation and invasion via upregulation of the RhoA/Rac2 signaling.
Zhang JY; Weng MZ; Song FB; Xu YG; Liu Q; Wu JY; Qin J; Jin T; Xu JM
Int J Oncol; 2016 Apr; 48(4):1590-8. PubMed ID: 26892468
[TBL] [Abstract][Full Text] [Related]
16. ECT2 regulates the Rho/ERK signalling axis to promote early recurrence in human hepatocellular carcinoma.
Chen J; Xia H; Zhang X; Karthik S; Pratap SV; Ooi LL; Hong W; Hui KM
J Hepatol; 2015 Jun; 62(6):1287-95. PubMed ID: 25617497
[TBL] [Abstract][Full Text] [Related]
17. Decreased expression of ARID1A associates with poor prognosis and promotes metastases of hepatocellular carcinoma.
He F; Li J; Xu J; Zhang S; Xu Y; Zhao W; Yin Z; Wang X
J Exp Clin Cancer Res; 2015 May; 34(1):47. PubMed ID: 25975202
[TBL] [Abstract][Full Text] [Related]
18. Caveolin-1 overexpression is associated with hepatocellular carcinoma tumourigenesis and metastasis.
Tse EY; Ko FC; Tung EK; Chan LK; Lee TK; Ngan ES; Man K; Wong AS; Ng IO; Yam JW
J Pathol; 2012 Mar; 226(4):645-53. PubMed ID: 22072235
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of CXCL5 mediates neutrophil infiltration and indicates poor prognosis for hepatocellular carcinoma.
Zhou SL; Dai Z; Zhou ZJ; Wang XY; Yang GH; Wang Z; Huang XW; Fan J; Zhou J
Hepatology; 2012 Dec; 56(6):2242-54. PubMed ID: 22711685
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of a novel activator of PAK4, the CDK5 kinase-associated protein CDK5RAP3, promotes hepatocellular carcinoma metastasis.
Mak GW; Chan MM; Leong VY; Lee JM; Yau TO; Ng IO; Ching YP
Cancer Res; 2011 Apr; 71(8):2949-58. PubMed ID: 21385901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]